Mindpeak and Proscia have announced a partnership to broaden access to improved diagnosis for cancer patients. Through the collaboration, the companies laid the foundation for delivering tightly integrated AI-powered workflows that enable pathologists to provide more efficient, informed, and reproducible clinical decisions.
The newly announced partnership paves the way for delivering an integrated solution that brings together Mindpeak’s CE-IVD algorithms for immunohistochemistry (IHC) quantification with Proscia’s CE-IVDR Concentriq Dx software platform.
